Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 1508 Results Clear All
A new discovery reveals how a SARS-CoV-2 protein reprograms immune cells to accelerate viral spread—and points to a new strategy for therapeutic intervention.
News Release Ott Lab COVID-19 Infectious Disease
The fellowship provides three years of funding for graduate students pursuing groundbreaking immunology research.
Marson Lab Genomic Immunology Philanthropy Cancer
Takahashi is recognized for his pioneering work translating iPS cell technology into a clinically approved therapy for Parkinson’s disease.
Ogawa Stem Cell Prize Stem Cells/iPSCs Regenerative Medicine News Release Awards
An unprecedented map of 22 million immune cells provides the functional rulebook for virtual biology and next-generation immunotherapies.
Marson Lab Genomic Immunology Cancer Autoimmune Diseases News Release
In this video, Gladstone scientists Emma Dann and Ronghui Zhu explain how their new study offers a powerful framework for designing cancer immunotherapies and treating autoimmune conditions.
CNN—Gladstone Investigator Nevan Krogan says the new autism research provides an important roadmap for understanding autism and identifying potential treatments.
Krogan Lab Autism
NPR—Gladstone Investigator Nevan Krogan discusses how researchers are connecting hundreds of autism-linked genes to the proteins they affect, helping identify common biological pathways that could lead to new treatments.
Krogan Lab Autism
Quantitative Biosciences Institute—A group of scientists, led by Gladstone Investigator Nevan Krogan, studied 100 autism risk genes and found that many patient-derived mutations disrupt core biological processes—a discovery that opens new avenues for future interventions.
Michael Alexanian is studying two promising genetic avenues for addressing heart failure, a massive global health burden in need of innovative treatments.
Alexanian Lab Cardiovascular Disease Human Genetics Grants Congenital Heart Disease
Meet Lexi Schneider, a PhD student using innovative technology to better understand the blood brain barrier.
Profile Graduate Students and Postdocs Yang Lab
TIME—Gladstone Investigator Shinya Yamanaka reflects on the past 20 years since his groundbreaking discovery of iPS cells and its potential to transform human health.
Yamanaka Lab Stem Cells/iPSCs iPS Cell Research Center
Parker Institute for Cancer Immunotherapy—Five investigators, including Jingya Qiu, will receive more than $1 million in combined funding to advance research projects that will accelerate the development of next-generation immunotherapies for cancer patients.
Cancer Parker Institute for Cancer Immunotherapy
Nature—20 years after his discovery of iPS cells, Gladstone Investigator Shinya Yamanaka comments on the field’s progress toward clinical therapies.
Yamanaka Lab Stem Cells/iPSCs
New York Times—Gladstone Investigator Lennart Mucke comments on the connection between epilepsy and dementia, noting that some dementia-like symptoms may be caused by epileptic activity and resolve with treatment. (Subscription required.)
Mucke Lab Alzheimer’s Disease Epilepsy Neurological Disease
Nature—Gladstone Investigator Shinya Yamanaka reflects on the 20th anniversary of the discovery of iPS cells and the field’s progress toward clinical therapies.
Yamanaka Lab Stem Cells/iPSCs
